Search - tctmd.com

Displaying 381 - 400 of 437

Sort: Relevancy | Date

News Conference News

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

November 07, 2011

News Conference News

DES and Stent Thrombosis Revisited

November 07, 2011

News Industry News

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

November 07, 2011

News Conference News

Evidence of Late Catch-up After DES ‘Unequivocal’

November 06, 2011

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Industry News

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

November 02, 2011

News Industry News

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

November 01, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

Advertisement

Efficacy of SES for In-stent Restenosis Dependent on Original Stent Type

DES and Stent Thrombosis Revisited

Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years

Evidence of Late Catch-up After DES ‘Unequivocal’

DES Noninferior for Survival Compared with BMS in STEMI

DES Associated with Less Downstream Lesion Development than BMS

Micell Technologies Announces Presentation of Clinical Data at TCT 2011

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Clinical Variables Added to Syntax Score Increases Predictive Ability

IVUS Guidance of DES Implantation Improves Outcomes

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

ESC Congress 2011: Drugs, Devices Work Together

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content